Literature DB >> 29769328

Proinflammatory enzyme soluble epoxide hydrolase bridges obesity to colonic inflammation and potential carcinogenesis.

Guang-Yu Yang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29769328      PMCID： PMC6003381          DOI： 10.1073/pnas.1807520115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  16 in total

1.  Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7.

Authors:  Naoki Matsumoto; Eriko Suzuki; Makoto Ishikawa; Takumi Shirafuji; Keiji Hasumi
Journal:  J Biol Chem       Date:  2014-10-31       Impact factor: 5.157

Review 2.  Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension.

Authors:  Isabella Sudano; Andreas J Flammer; Susanne Roas; Frank Enseleit; Georg Noll; Frank Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

3.  Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo.

Authors:  Suman Kundu; Talat Roome; Ashish Bhattacharjee; Kevin A Carnevale; Valentin P Yakubenko; Renliang Zhang; Sung Hee Hwang; Bruce D Hammock; Martha K Cathcart
Journal:  J Lipid Res       Date:  2012-11-15       Impact factor: 5.922

4.  Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events.

Authors:  Jun-Yan Liu; Ning Li; Jun Yang; Nan Li; Hong Qiu; Ding Ai; Nipavan Chiamvimonvat; Yi Zhu; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

5.  Reduction of inflammatory bowel disease-induced tumor development in IL-10 knockout mice with soluble epoxide hydrolase gene deficiency.

Authors:  Wanying Zhang; Jie Liao; Haonan Li; Hua Dong; Han Bai; Allison Yang; Bruce D Hammock; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2012-04-19       Impact factor: 4.784

6.  Epoxyeicosanoids promote organ and tissue regeneration.

Authors:  Dipak Panigrahy; Brian T Kalish; Sui Huang; Diane R Bielenberg; Hau D Le; Jun Yang; Matthew L Edin; Craig R Lee; Ofra Benny; Dayna K Mudge; Catherine E Butterfield; Akiko Mammoto; Tadanori Mammoto; Bora Inceoglu; Roger L Jenkins; Mary A Simpson; Tomoshige Akino; Fred B Lih; Kenneth B Tomer; Donald E Ingber; Bruce D Hammock; John R Falck; Vijaya L Manthati; Arja Kaipainen; Patricia A D'Amore; Mark Puder; Darryl C Zeldin; Mark W Kieran
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

7.  Soluble epoxide hydrolase disruption as therapeutic target for wound healing.

Authors:  Anna L Sander; Katharina Sommer; Thomas Neumayer; Ingrid Fleming; Ingo Marzi; John H Barker; Johannes Frank; Heike Jakob
Journal:  J Surg Res       Date:  2012-10-30       Impact factor: 2.192

Review 8.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Authors:  John D Imig; Bruce D Hammock
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

9.  Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.

Authors:  Wanying Zhang; Allison L Yang; Jie Liao; Haonan Li; Hua Dong; Yeon Tae Chung; Han Bai; Kristina A Matkowskyj; Bruce D Hammock; Guang-Yu Yang
Journal:  Dig Dis Sci       Date:  2012-05-16       Impact factor: 3.199

10.  Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation.

Authors:  Weicang Wang; Jun Yang; Jianan Zhang; Yuxin Wang; Sung Hee Hwang; Weipeng Qi; Debin Wan; Daeyoung Kim; Jia Sun; Katherine Z Sanidad; Haixia Yang; Yeonhwa Park; Jun-Yan Liu; Xinfeng Zhao; Xiaohui Zheng; Zhenhua Liu; Bruce D Hammock; Guodong Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-01       Impact factor: 11.205
View more
  2 in total

1.  Drug-Target Residence Time Affects in Vivo Target Occupancy through Multiple Pathways.

Authors:  Kin Sing Stephen Lee; Jun Yang; Jun Niu; Connie J Ng; Karen M Wagner; Hua Dong; Sean D Kodani; Debin Wan; Christophe Morisseau; Bruce D Hammock
Journal:  ACS Cent Sci       Date:  2019-09-03       Impact factor: 14.553

Review 2.  Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis.

Authors:  Ryan D Jones; Jie Liao; Xin Tong; Dandan Xu; Leyu Sun; Haonan Li; Guang-Yu Yang
Journal:  Front Pharmacol       Date:  2019-06-25       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.